‘Crazy Monkey’ Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid

@article{Gugelmann2014CrazyMP,
  title={‘Crazy Monkey’ Poisons Man and Dog: Human and canine seizures due to PB-22, a novel synthetic cannabinoid},
  author={Hallam M. Gugelmann and Roy R. Gerona and C. Li and Ben T. Tsutaoka and Kent R. Olson and Derrick D. Lung},
  journal={Clinical Toxicology},
  year={2014},
  volume={52},
  pages={635 - 638}
}
Abstract Context. Synthetic cannabinoids have been manufactured, sold, and consumed for recreational purposes since at least 2004; their use has been associated with adverse psychiatric, cardiovascular, renal, pulmonary, and neurologic effects. We report simultaneous canine and human clinical cases associated with exposure to a novel synthetic cannabinoid, PB-22 (QUPIC). Case report. A 22-year-old man brought his dog to a veterinary clinic after it had a seizure. During the course of the canine… 
Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation
TLDR
This is the first case report of non-fatal intoxication with 5F-AKB-48 with analytical confirmation and exposure times and highlights the difficulties in understanding the pattern of toxicity of certain SCRAs in the context of psychotropic medications/co-morbid mental illness.
Synthetic cannabinoids 2015: An update for pediatricians in clinical practice.
TLDR
Pediatricians are urged to familiarize themselves with these drugs and the typical presentations of patients who use them and the diagnosis remains primarily clinical with toxicological confirmation difficult due to manufacturers constantly developing new analogues to avoid detection.
Relation Between Acute Administration of Synthetic Cannabinoids and Induction of Epileptic Seizures
TLDR
Synthetic cannabinoid usage has been linked to seizure induction and has been shown to alter electroencephalographic activity.
Use of gas chromatography-mass spectrometry for definitive diagnosis of synthetic cannabinoid toxicity in a dog.
TLDR
This is the first report to describe utilization of gas chromatography-mass spectrometry on canine plasma to reach a definitive diagnosis of synthetic cannabis toxicosis in a dog.
Exposure to drugs of abuse
TLDR
Clinical signs after exposure to recreational drugs are often rapid in onset and gastric decontamination may not be appropriate, so supportive care, managing stimulant effects and supporting the cardiovascular and respiratory systems are important.
Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
TLDR
Given the rapid increase in the use of synthetic cathinones and cannabinoid designer drugs, their potential for dependence and abuse, and harmful medical and psychiatric effects, there is a need for research and education in the areas of prevention and treatment.
Toxicology of Marijuana, Synthetic Cannabinoids, and Cannabidiol in Dogs and Cats.
Dark Classics in Chemical Neuroscience: Synthetic Cannabinoids (Spice / K2).
TLDR
Overall, the emergence of synthetic cannabinoids serves as a noteworthy example of the pressing public health challenges associated with the increasing development of easily synthesized, structurally-flexible, highly-potent, psychoactive drugs.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Convulsions Associated with the Use of a Synthetic Cannabinoid Product
TLDR
The absence of anticonvulsant phytocannabinoids in spice products could potentially be one of multiple unknown mechanisms contributing to convulsions.
First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201
TLDR
It is important for emergency physicians, clinical toxicologists and clinical pharmacologists managing those presenting with acute toxicity related to the use of SCRA to analytically confirm the exact compound(s) involved, to enable accurate description of the acute toxicity associated with individual SCRA.
Acute Kidney Injury Associated with Synthetic Cannabinoid Use — Multiple States, 2012
TLDR
The results of the investigation determined that no single SC brand or compound explained all 16 cases, and public health practitioners, poison center staff members, and clinicians should be aware of the potential for renal or other unusual toxicities in users of SC products and should ask about SC use in cases of unexplained AKI.
Synthetic cannabis and acute ischemic stroke.
Complication of spice use in a deployed combat setting-seizure while on duty.
TLDR
A case of a deployed soldier who had a seizure after smoking Spice while on duty, and just after working with heavy machinery is presented.
High Times, Low Sats: Diffuse Pulmonary Infiltrates Associated with Chronic Synthetic Cannabinoid Use
TLDR
This case contributes to the currently evolving knowledge about SC agents, adding a rarely described pulmonary complication to the growing list of adverse effects associated with these products.
Severe Illness Associated with Synthetic Cannabinoid Use — Brunswick, Georgia, 2013
TLDR
Investigators reviewed recent medical records of patients who had gone to the emergency department and found that 22 patients had been examined after using synthetic cannabinoids during August 22-September 9, 2013.
The Endogenous Cannabinoid System Regulates Seizure Frequency and Duration in a Model of Temporal Lobe Epilepsy
TLDR
A role for the endogenous cannabinoid system in modulating neuroexcitation is defined and plasticity of the CB1 receptor occurs with epilepsy, and data indicate not only anticonvulsant activity of exogenously applied cannabinoids but also suggest that endogenous cannabinoid tone modulates seizure termination and duration.
Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716.
TLDR
These findings confirm, for the first time in humans, the central role of CB1 receptors in mediating the effects of marijuana.
Evidence for novel cannabinoid receptors.
...
1
2
3
...